Active Funding
2023 – 2027: R01AG078657, National Institute on Aging (Roussos MPI)
Identifying genetically driven gene dysregulation in Alzheimer’s disease and related dementias using statistical data integration
2023 – 2026: R01MH133703, National Institute of Mental Health (Roussos MPI)
Towards an integrated analytics solution to creating a spatially-resolved single-cell multi-omics brain atlas
2023 – 2026: BD² Breakthrough Discoveries for thriving with Bipolar Disorder (Roussos PI)
Dissection of Bipolar Disorder pathophysiology through integration of human brain multi-omics
2023 – 2028: R01AG082185, National Institute of Health/Aging (Roussos MPI)
The adaptive-innate immune interactome across multiple tissues in Alzheimer’s disease
2021 – 2026: R01AG050986, National Institute of Health/Aging (Roussos PI)
Higher Order Chromatin and Genetic Risk for Alzheimer’s Disease
2021 – 2025: R01MH125246, National Institute of Mental Health (Roussos PI)
Multiethnic genomic, epigenomic and transcriptomic fine-mapping and functional validation analysis of schizophrenia and bipolar disorder risk loci
2023 – 2025: Foundation for the NIH (Roussos PI)
STARNET – a multi-tissue omics resource obtained from living patients with cardiometabolic diseases
2020 – 2025: R01AG065582, National Institute of Health/Aging (Roussos PI)
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
2019 – 2024: NIH/NIMH/Jefferson University (Roussos Subaward PI)
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
2021 – 2024: RF1MH128970, National Institute of Mental Health (Roussos PI)
A regulome and transcriptome atlas of fetal and adult human neurogenesis
2019 – 2024: R01DA047880, National Institute on Drug Abuse (Roussos MPI)
Transcriptome and Epigenome Mapping in Dopamine Neurons from the Opioid Exposed Human Brain
2019 – 2024: R01AG067025, National Institute of Health/Aging (Roussos PI)
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease
2018 – 2024: U01MH116442, National Institute of Mental Health (Roussos MPI)
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorder
2019 – 2024: U01DA048279, National Institute on Drug Abuse (Roussos MPI)
Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease
Previous Funding
2021 – 2023: U01NS125580, National Institute of Neurological Disorders and Stroke (Roussos PI) Single-nucleus transcriptome profiling across multiple brain regions in Parkinson’s Disease
2018 – 2020: Merit BX004189, Veterans Administration (Roussos PI) Large-scale transcriptome and epigenome association analysis across multiple traits.
2017 – 2020: R01AG057440, National Institute of Aging (Roussos M-PI) Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimer’s Disease.
2017 – 2019: Boehringer Ingelheim, LTD (Roussos PI) Multiregional assessment of cell type specific epigenome and transcriptional profiling in human brain tissue.
2016 – 2021: R01MH109677, National Institute of Mental Health (Roussos PI) Risk genetic variants and cis regulation of gene expression in Bipolar Disorder.
2016 – 2021: R01MH109897, National Institute of Mental Health (Roussos M-PI) Integrated Multiscale Networks in Schizophrenia.
2016 – 2020: R01MH110921, National Institute of Mental Health (Roussos PI) Molecular Profiling of Schizophrenia.
2016 – 2021: Presidential Early Career Awards for Scientists and Engineers (PECASE), White House (Roussos PI)
2015 – 2020: R01AG050986,National Institute of Aging (Roussos PI) Higher Order Chromatin and Genetic Risk for Alzheimer’s Disease.
2015 – 2018: R01MH106056,National Institute of Mental Health (Roussos M-PI) Higher Order Chromatin and Genetic Risk for Schizophrenia.
2013 – 2022: Merit BX002395,Veterans Administration (Roussos PI) Dissecting cis regulation of gene expression in schizophrenia.
2016 – 2017: Research Grant, Charleston Conference on Alzheimer’s Disease
2015 – 2017: NIRG-340998, Alzheimer’s Association
2013 – 2015: Young Investigator Award, National Alliance for Research on Schizophrenia and Depression (NARSAD)
2013 – 2014: Research Grant, American Psychiatric Association (APA)